Literature DB >> 11740988

Imaging of lung cancer with CT, MRT and PET.

U Haberkorn1, S O Schoenberg.   

Abstract

The staging of non-small lung cancer has to be performed in an interdisciplinary approach considering all clinical, radiological and histologic results. The staging using imaging procedures is done according to the TNM classification with T describing the extent of the primary tumor, N the presence and location of metastatic lymph nodes and M the presence or absence of distant metastases. It is important to remember that the individual stages of the TNM classification have undergone numerous revisions and thus need to be considered in their most recent version [Chest 111 (1997) 1718; Chest 111 (1997) 1710]. Noninvasive information about the stage of the disease is important for the planning and optimization of therapy. This may be done with imaging procedures such as, CT, MRT or PET.

Entities:  

Mesh:

Year:  2001        PMID: 11740988     DOI: 10.1016/s0169-5002(01)00369-5

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  6 in total

Review 1.  Combined PET/MRI: a new dimension in whole-body oncology imaging?

Authors:  Gerald Antoch; Andreas Bockisch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

Review 2.  Lymph node dissection--understanding the immunological function of lymph nodes.

Authors:  M Buettner; U Bode
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

3.  Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios may aid in identifying patients with non-small cell lung cancer and predicting Tumor-Node-Metastasis stages.

Authors:  Fei Xu; Pengliang Xu; Wenqiang Cui; Weiyi Gong; Ying Wei; Baojun Liu; Jingcheng Dong
Journal:  Oncol Lett       Date:  2018-05-07       Impact factor: 2.967

4.  Screening of brain metastasis with limited magnetic resonance imaging (MRI): clinical implications of using limited brain MRI during initial staging for non-small cell lung cancer patients.

Authors:  Sun Young Kim; Jae Sung Kim; Hee Sun Park; Moon June Cho; Ju Ock Kim; Jin Whan Kim; Chang Jun Song; Seung Pyung Lim; Sung Soo Jung
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

Review 5.  [Whole-body tumor staging: MRI or FDG-PET/CT?].

Authors:  G Antoch; F M Vogt; A Bockisch; S G Ruehm
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

Review 6.  Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer.

Authors:  Henk Kramer; Harry J M Groen
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.